Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/THIRD-HARMONIC-BIO-INC-143774951/news/Third-Harmonic-Bio-gibt-den-Abbruch-der-Phase-1B-Studie-von-Thb001-bei-chronischer-induzierbarer-Urt-42563037/?utm_source=whatsapp&utm_medium=social&utm_campaign=share